Company Filing History:
8 out of 447 
4 out of 20 
1 out of 5 Years Active: 2005-2022
Title: The Innovative Contributions of Dennis Hall
Introduction
Dennis Hall is a prominent inventor based in Edmonton, Canada, known for his significant contributions to the field of biochemistry and cancer research. With a total of eight patents to his name, Hall has made strides in developing novel compounds that have the potential to impact cancer treatment.
Latest Patents
Among his latest patents, Hall has developed imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase. This innovation is crucial as it explores new avenues for cancer therapy. Additionally, he has worked on methods for inducing synthetic lethality in cancer cells, which could lead to more effective treatment strategies for patients.
Career Highlights
Throughout his career, Dennis Hall has been associated with esteemed institutions such as the University of Alberta and Alberta Health Services. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Hall has collaborated with notable colleagues, including Michael Weinfeld and Todd Randall Mereniuk. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Dennis Hall's innovative work and dedication to cancer research exemplify the vital role of inventors in advancing medical science. His patents reflect a commitment to finding new solutions for complex health challenges.